Navigation Links
Alseres Pharmaceuticals, Inc.'s Chairman, Peter Savas, Reviews Company's Progress in its Annual Letter to Stockholders
Date:6/12/2008

ates, Canada, Europe

and other selected countries.

-- Cethrin works by inhibiting the action of Rho, a key enzyme that

prevents axon (nerve) regeneration. Rho potentially plays an important

role in a wide range of indications, including acute spinal cord injury,

stroke, bone regeneration, cardiomyopathy and oncology. Alseres has

ongoing, sponsored-research for approaches to activate pro-regenerative

pathways that stimulate axon regeneration and for approaches to

deactivate anti-regenerative pathways that inhibit axon regeneration.

We believe that our Rho inhibitor technology is a fertile and

potentially valuable platform for continued new product research and

development.

-- Altropane(R), the company's lead molecular imaging product candidate,

is in Phase III clinical trials for the diagnosis of Parkinson's

Disease in patients with tremor. After a series of discussions with

the FDA and our expert advisors, we designed a two-part Phase III

program, termed POET-2. The first part of the program is presently

enrolling patients, as planned, in a 7-center clinical study to

generate an image training set. These images will be used to train the

expert readers in the study, as is customary for clinical trials of

molecular imaging agents. The second part of the program involves two

concurrent, replicate Phase III trials which are planned to be

initiated as soon as final agreement with FDA is reached. In addition,

by the end of the year, we plan to begin Phase II trials of Altropane,

in a new indication to aid in the diagnosis of Dementia with Lewy

Bodies "DLB".

-- We entered into an option agreement whereby Alseres can exercise an

option to amend certain terms of its Cethrin license with BioAxone

Therapeutic, Inc. in exchange f
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
2. Alseres Pharmaceuticals, Inc. Raises $5 Million
3. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
4. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
5. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
6. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
7. Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
8. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The new http://www.carsonenergy.com includes ... should consider oil and gas investing, the substantial tax ... drilled, industry news, IRA investing, definitions and acronyms, info-graphics ... knowledge and experience is now in one central location, ... able to access 24 hours a day, 7 days ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 The ... announce a partnership to provide CMSA's Career and ... This collaboration seeks to strengthen the case/care management ... CMSA’s CKP program. The mutually beneficial agreement provides ... individual skills of talent in the healthcare, scientific ...
(Date:5/27/2015)... Coco Libre announced today that artists and audiences at ... Coconut Water to quench their thirst during the festival May ... artist greenrooms, corporate skyboxes and concessions areas at the venue. ... festival shuttle buses. , “We’re excited to have Coco ... of Strategic Partnerships for Latitude 38 Entertainment, producer of the ...
(Date:5/27/2015)... Meadows, IL (PRWEB) May 27, 2015 ... release of its SonarMD Platform, a first-of-its ... monitoring and managing patients with chronic gastrointestinal ... Kosinski, MD, MBA, the application allows physicians ... visits through the ongoing use of electronic ...
(Date:5/27/2015)... 2015 SmarterSkin, http://www.smarterskindermatology.com , is taking ... test that makes it easier for patients to find skin ... , Dr. Sejal Shah is a cosmetic dermatologist based in ... offer the test. This revolutionary DNA test uses 16 genetic ... aging: , 1. Firmness and elasticity , 2. ...
Breaking Medicine News(10 mins):Health News:Carson Energy Launches Next Generation Investor Website 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2
... Universal Banking at the Heart of Tanzanian Bank,s,Expansion Plans, ... and services,company, today announces that CRDB Bank of Tanzania ... 1996, CRDB Bank is entering a period of renewed,expansion ... launch a fully,automated and integrated banking service and add ...
... review board, today announced that they have appointed Michael Malafronte to ... Malafronte brings to Quorum 24 years of executive experience with quality ... Michael will lead Quorum in continuous quality improvement. , ... ...
... families experience a high degree of interpersonal conflict have ... with Asian Americans overall, according to a new study ... tripled even among those who have never had a ... reported during a 2 p.m. (EDT) poster session, "Improving ...
... half of 26,000 students across 70 colleges and universities ... at least one episode of suicidal thinking at some ... surveyed reported having seriously considered attempting suicide and more ... least once in their lifetime. , Presenting Sunday at ...
... recent recall notice for the heart drug Digitek, the ... on how long the heart medication was being improperly ... manufacturer, some Digitek tablets may have been manufactured at ... a double dose of the drug, leading to an ...
... Statement Attributable to: Linda L. Kloss, MA, RHIA AHIMA Chief ... ... American Health Information,Management Association is excited to hear the Centers for ... as a significant step forward in the march toward the use ...
Cached Medicine News:Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 2Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 3Health News:Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration 2Health News:Suicide in Asian Americans 2Health News:Suicidal thoughts among college students more common than expected 2Health News:Suicidal thoughts among college students more common than expected 3Health News:Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity 2Health News:Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity 3
(Date:5/27/2015)... , May 27, 2015 /PRNewswire/ ... MXIM ) makes it easy to ... to monitor or control unsanitary reuse ... gamma-radiation-resistant, nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s ...
(Date:5/27/2015)...  Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce ... Financial Officer, will present at the Jefferies 2015 Global Healthcare ... New York City . The ... the Cambrex website at www.cambrex.com in the Investors ... available for 90 days after the live event concludes.  ...
(Date:5/27/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... announced an upcoming poster presentation regarding its lead drug ... Oncology (ASCO) Annual Meeting, which is being held May ... . "I am impressed by the ... who have undergone treatment with aldoxorubicin across several cancer ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 2CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 4CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 5
... MIAMI , July 12 Fuisz Pharma today announced that ... Dye" (invented by Dr. Thomas Gruber )).  This patent covers the ... method to prevent the improper use of opiate derived drugs by visually ... , Fuisz ...
... Surgical Technology, Inc. recently expanded its Biologics Product Specialist program to provide ... that address bone and soft tissue repair. , ... Mr. Shane Ray , General Manager for ... innovative biologic products and to compete with well established biologic providers in ...
Cached Medicine Technology:Fuisz Pharma Announces Acquisition of Key Anti Opiate Abuse Patent to Complement its Anti Opiate Abuse Platform 2Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business 2
SCD Sequential Compression System Intermittent Pneumatic Compression...
Classic black cast boot with unisex styling...
The Multi-Purpose Medical-Surgical Shoe...
... enzyme-linked immunosorbent assay for the ... IgA-class antibodies to Gliadin in ... is intended to be used ... diagnosis of gastrointestinal disorders, manily ...
Medicine Products: